Observational cohort study (n=500) evaluating real-world home and clinic ketamine treatment plans for people with chronic conditions (pain, depressive and anxiety disorders) and the effect of adjunct therapies.
This observational cohort (cross-sectional elements) will characterise how ketamine is prescribed and delivered off-label across chronic conditions, including routes (IV, IM, SubQ, sublingual and others), dosing patterns, and concurrent treatments.
The study will document adjunct modalities (psychotherapy, music therapy, acutherapy) and examine associations between adjunct use and clinical outcomes for pain, mood and anxiety.
A secondary focus is the relationship between ketamine treatment and suicidal ideation among participants with chronic conditions.
The use of ketamine in chronic pain
IV/IM/SubQ/Sublingual and other routes used per clinician; dosing per treating clinician.
The use of ketamine in depressive disorders
IV/IM/SubQ/Sublingual and other routes used per clinician; dosing per treating clinician.
The use of ketamine in anxiety disorders
IV/IM/SubQ/Sublingual and other routes used per clinician; dosing per treating clinician.
The use of ketamine in chronic conditions
IV/IM/SubQ/Sublingual and other routes used per clinician; dosing per treating clinician.